APAC Biotech
OverviewSuggest Edit
APAC Biotech is a biotechnology company involved in research and manufacture of dendritic cell-based immunotherapy. Its solution can be used to enhance the patient’s immune response against cancer.
| Type | Private | |
| Founded | 2010 | |
| Website | apacbiotech.com |
Latest Updates
| Employees (est.) (Jun 2021) | 15 | |
| Cybersecurity rating | A | More |
APAC Biotech Financials and Metrics
Summary Metrics
Founding Date | 2010 |
APAC Biotech Cybersecurity Score
APAC Biotech Online and Social Media Presence
APAC Biotech's Trends
Twitter Engagement Stats for @apacbiotech
104
Tweets
149
Following
58
Followers
2
Tweets last 30 days
0
Avg. likes per Tweet
50%
Tweets with engagement
APAC Biotech News and Updates
July 23, 2020
APAC Biotech Awarded Patent for Maturation and Production of Dendritic Cells as a Personalized Immunotherapy Treatment for Cancer
APCEDEN®, APAC's immunotherapy product, has already been approved by the Indian FDA for treating cancer. The company has further announced it will conduct clinical trials for highly aggressive brain tumors (GBM) and pancreatic cancers (PDAC) with its new technology.
APAC Biotech Frequently Asked Questions
When was APAC Biotech founded?
APAC Biotech was founded in 2010.
How many employees does APAC Biotech have?
APAC Biotech has 15 employees.
Who are APAC Biotech competitors?
Competitors of APAC Biotech include WindMIL Therapeutics, Vaccitech and Dendreon.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies